Anxiofit‐1 and reduction of subthreshold and mild anxiety: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
Abstract Following an application from Anxiofit Ltd. and ExtractumPharma Co Ltd., submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Hungary, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked...
Main Author: | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | EFSA Journal |
Subjects: | |
Online Access: | https://doi.org/10.2903/j.efsa.2016.4365 |
Similar Items
-
Anxiofit‐1 and reduction of subthreshold and mild anxiety: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2020-10-01) -
Scientific Opinion on the substantiation of a health claim related to choline and "development of brain" pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2014-05-01) -
Scientific Opinion on the substantiation of a health claim related to caffeine and increased alertness pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2014-02-01) -
Scientific Opinion on the substantiation of a health claim related to zinc and normal growth pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2014-11-01) -
Scientific Opinion on the substantiation of a health claim related to collagen hydrolysate and maintenance of joints pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2011-07-01)